BioAesthetics Announces Additional Clinical Study for NACgraft

NACgraft Aims to Improve Quality-of-Life for Breast Cancer Patients RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–BioAesthetics Corporation today announced an additional clinical study for the BioAesthetics® NACgraft™ Acellular Allograft that will investigate its performance in subpopulations of breast cancer survivors and other individuals needing nipple reconstruction. The previously announced study at Stanford Medicine focuses on female breast … [Read more…]

ESMO Partners with Total Health Conferencing in Organization’s First-Ever Expansion into the US, Increasing Access to New Oncology Medical Education

Collaboration will bring the latest developments in the management of cancer presented at the ESMO Congress to US-based doctors for the first time in three hybrid virtual / live conferences LUGANO, Switzerland & BOCA RATON, Fla.–(BUSINESS WIRE)–Total Health Conferencing, a medical information company that produces tailored content, courses, and conferences for oncology healthcare providers, today … [Read more…]

Optime Care Receives 2022 Sales and Marketing Technology Award

EARTH CITY, Mo.–(BUSINESS WIRE)–Today, the Business Intelligence Group named Optime Care Organization of the Year in the 2022 Sales and Marketing Technology Awards program, also known as The Sammys. The Sammys honor organizations connecting and collaborating with prospects and customers. Darcey McDermott, Chief Marketing and Communications Officer, AscellaHealth Family of Companies and parent company to … [Read more…]

LAMEA Peptide Therapeutics Market Report 2022: Featuring Key Players Eli Lilly And Company, AstraZeneca, Pfizer, GlaxoSmithKline & Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “LAMEA Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Innovative and Generic), By Route of Administration, By Synthesis Technology, By Type of Manufacturers, By Application, By Country and Growth Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Latin America, Middle East and Africa Peptide Therapeutics … [Read more…]

AnHeart Therapeutics to Present Poster and Host Investigator Meeting at WCLC 2022

NEW YORK–(BUSINESS WIRE)–#IASLC—AnHeart Therapeutics today announced it will host an investigator meeting in addition to a e-poster presentation at the World Conference on Lung Cancer (WCLC) in Vienna, Austria at 11:00 am ET on Sunday, Aug. 7, 2022. Ignatius Ou, M.D., Ph.D., Professor of Medical Oncology, University of California Irvine School of Medicine, along with … [Read more…]

Rite Aid Opens Online Scheduling for Flu Vaccines at All Locations

Customers can now schedule online for appointments beginning today or walk in at Rite Aid and Bartell Drug’s locations PHILADELPHIA–(BUSINESS WIRE)–It’s not too early to schedule your flu shot. Rite Aid (NYSE: RAD) has opened online scheduling for flu shots at its locations including Bartell Drugs in the Pacific Northwest, and is now accepting walk-ins, … [Read more…]

Vacmobile Joins Georgia Tech’s Advanced Technology Development Center’s Accelerate Startup Portfolio

Vacmobile offers unique, globally scalable, rapidly deployable solution ATLANTA–(BUSINESS WIRE)–Vacmobile Corporation, a leader in the digital transformation of vaccination and test records, today announced it has been accepted into the Advanced Technology Development Center’s ATDC Accelerate startup portfolio. A program of Georgia Tech’s Enterprise Innovation Institute, ATDC is the state of Georgia’s technology startup incubator. … [Read more…]

Sagimet Biosciences Announces Oral Presentation on Denifanstat at Keystone Symposia in Nonalcoholic Steatohepatitis (NASH)

SAN MATEO, Calif.–(BUSINESS WIRE)–#Clinicaltrials–Sagimet Biosciences, a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways, announced today that it will present additional Phase 2a data highlighting improved lipid composition and potential cardiovascular benefits of denifanstat in nonalcoholic steatohepatitis (NASH) patients. Denifanstat (formerly TVB-2640), the company’s lead product candidate, is an oral, selective, first-in-class fatty … [Read more…]

HeartBeam Names Ken Persen as Chief Technology Officer

Company Hires Cardiac Industry Veteran to Lead Technology Development SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, announced today the appointment of Ken Persen to the role of Chief Technology Officer. Persen has extensive technology, executive and start-up experience in … [Read more…]

Trinity Life Sciences Acquires Vancery’s Customer Research Technology

Asset Acquisition Enables Trinity to Better Connect with Healthcare Professionals WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced it signed an asset purchase agreement for the acquisition of Vancery’s customer research technology. The investment expands Trinity’s insights and analytics product offerings, allowing the company to better connect with healthcare … [Read more…]